This trial will use implanted markers to determine the feasibility of Markerless Image Guidance using Intrafraction Kilovoltage X-ray Imaging. It is a Phase I Interventional Study of Lung Cancer Radiotherapy. The goal is to determine wether Markerless Tumour Tracking is feasible for motion-adaptive lung cancer radiotherapy.
Study size: 30 patients
Study Site: The Alfred Hospital
Study Protocol publication: https://pubmed.ncbi.nlm.nih.gov/35058267/
More information: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=22164&isClinicalTrial=True